Research Paper Volume 11, Issue 16 pp 6286—6311

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis

Figure 5. Bayesian network meta-analysis for grade 3–4 hematological adverse events. (A) The league table for comparisons of anemia. (B) The league table for comparisons of neutropenia. (C) The league table for comparisons of thrombocytopenia. Data are presented as odds radio (OR) and 95% confidence intervals (CI). An OR>1 favors the row-defining treatment, and OR<1 favors the column-defining treatment.